Lenalidomide Mylan 欧州連合 - ギリシャ語 - EMA (European Medicines Agency)

lenalidomide mylan

mylan ireland limited - λεναλιδομίδη - Πολλαπλό μυέλωμα - Ανοσοκατασταλτικά - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).

FUCIDIN 1% EY.DRO.SUS ギリシャ - ギリシャ語 - Εθνικός Οργανισμός Φαρμάκων

fucidin 1% ey.dro.sus

leo pharmaceutical products hellas ltd - fusidic acid - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΕΝΑΙΩΡΗΜΑ - 1% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

FUCIDIN 1% W/W (1 Δόση) EY.DRO.SUS ギリシャ - ギリシャ語 - Εθνικός Οργανισμός Φαρμάκων

fucidin 1% w/w (1 δόση) ey.dro.sus

leo pharmaceutical products hellas ltd - fusidic acid - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΕΝΑΙΩΡΗΜΑ - 1% w/w (1 Δόση) - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Flebogamma DIF (previously Flebogammadif) 欧州連合 - ギリシャ語 - EMA (European Medicines Agency)

flebogamma dif (previously flebogammadif)

instituto grifols s.a. - Ανθρώπινη φυσιολογική ανοσοσφαιρίνη - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - Άνοσοι οροί και ανοσοσφαιρίνες, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.

Vidaza 欧州連合 - ギリシャ語 - EMA (European Medicines Agency)

vidaza

bristol-myers squibb pharma eeig - αζακιτιδίνη - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - Αντινεοπλασματικοί παράγοντες - vidaza is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with: intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification. vidaza is indicated for the treatment of adult patients aged 65 years or older who are not eligible for hsct with aml with >30% marrow blasts according to the who classification.

BETAISODONA SKIN CLEANSER 4% W/V CUTANEOUS SOLUTION キプロス - ギリシャ語 - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

betaisodona skin cleanser 4% w/v cutaneous solution

mundipharma pharmaceuticals ltd (0000003104) 13 othellos str, nicosia, 1685, 23661 - povidone-iodine - cutaneous solution - 4% w/v - povidone-iodine (0025655418) 4% w/v - povidone-iodine

CISPLATIN 1MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION キプロス - ギリシャ語 - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

cisplatin 1mg/ml concentrate for solution for infusion

pfizer hellas ae (0000003442) 243 messoghion avenue, neo psychiko, athens, 15451 - cisplatin - concentrate for solution for infusion - 1mg/ml - cisplatin (0015663271) 1mg - cisplatin

MENINGOCOCCAL POLYSACCHARIDE VACCINE A+C キプロス - ギリシャ語 - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

meningococcal polysaccharide vaccine a+c

sanofi pasteur. - neisseria meningitidis a,ΠΟΛΥΣΑΚΧΑΡΊΤΗ, ΜΗΝΙΓΓΙΤΙΔΌΚΟΚΚΟΣ c,ΠΟΛΥΣΑΚΧΑΡΊΤΗ - powder & solvent for suspension for injection - 100mcg - 8000000697 - neisseria meningitidis a,polysaccharide - 50 ug; 8000000698 - neisseria meningitidis c,polysaccharide - 50 ug - meningococcus, bivalent purified polysacc. antigen

PENTAXIM POWDER & SUSPENSION FOR SUSPENSION FOR INJECTION キプロス - ギリシャ語 - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

pentaxim powder & suspension for suspension for injection

sanofi pasteur. (0000010487) 14 espace henry vallee, lyon, 69007 - diphtheria toxoid; poliomyelitis virus type 3; tetanus toxoid; pertussis toxoid(pt); filamentous haemagglutinin (fha); poliomyelitis virus type 2; poliomyelitis virus type 1; haemophilus infl. type b polys.conj.t.toxoid - powder & suspension for suspension for injection - diphtheria toxoid (8000000804) 0iu; poliomyelitis virus type 3 (8000000485) 32du; tetanus toxoid (8000040440) 0iu; pertussis toxoid(pt) (8000001811) 25mcg; filamentous haemagglutinin (fha) (8000001813) 25mcg; poliomyelitis virus type 2 (8000000484) 8du; poliomyelitis virus type 1 (8000000483) 40du; haemophilus infl. type b polys.conj.t.toxoid (8000001810) 10mcg - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus

SEPTOBORE EYE DROPS キプロス - ギリシャ語 - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

septobore eye drops

cooper pharmaceuticals sa (cooper s.a.) (0000008762) 64 aristovoulou str, athens, 118 53 - boric acid; naphazoline nitrate - eye drops - boric acid (0010043353) 10mg; naphazoline nitrate (0005144525) 1mg - naphazoline, combinations